Brief: Brickell Biotech Regains Compliance With Nasdaq Minimum Bid Price Requirement
20/07/2022 14:47
July 20 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH REGAINS COMPLIANCE WITH NASDAQ MINIMUM
BID
PRICE REQUIREMENT
Source text for Eikon: ID:nGNXbwNY6n
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx